-
1 Comment
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd is currently in a long term uptrend where the price is trading 37.7% above its 200 day moving average.
From a valuation standpoint, the stock is 53.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd's total revenue rose by 32.2% to $1B since the same quarter in the previous year.
Its net income has increased by 885.5% to $391M since the same quarter in the previous year.
Finally, its free cash flow fell by 58.7% to $177M since the same quarter in the previous year.
Based on the above factors, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE1000009X3 |
| Target Price | 47.87 |
|---|---|
| Dividend Yield | 2.1% |
| Beta | 0.39 |
| Market Cap | 38B |
| PE Ratio | 21.78 |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages provision of home medical devices, medical clinical products, and related services in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monitors, oximeters, and thermometers; wheelchairs; AEDs; and traditional Chinese medicine product solutions. The company was formerly known as Yuwell medical. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. was founded in 1998 and is based in Danyang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002223.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
